Continuous Renal Replacement Therapy, Hemofilter Clotting, Renal Failure
Conditions
Keywords
crrt, continuous renal replacement therapy, hemofilter clotting, post-filter hematocrit, filtration fraction
Brief summary
Filter clotting is a major complication of continuous renal replacement therapy (CRRT), resulting in blood loss, reduced treatment efficacy, and increased cost. One modifiable factor associated with filter clotting is filtration fraction (FF), or the proportion of plasma water being removed from the blood over the course of the filter. In convention, a cutoff of FF\<20-30% has been used to prevent hemofilter clotting, but no evidence correlating FF with hemofilter clotting has been documented. Some experts have proposed that post-filter hematocrit (Hct) could be a more direct marker for determining hemofilter clotting risk, but evidence supporting clinical utility of this marker is lacking. HCTpost=HCTpre/(FF(HCTpre-1)+1) In our proposed validation study, we hope to determine whether our formula for post-filter Hct provides accurate results when compared to measured values. The information obtained from this study will potentially justify the use of utilizing the formula in future studies. The procedure of this study is collecting blood samples from the post-filter lines of patients on CRRT at different time points and different flow rates. This will be considered the measured post-filter hematocrit which will then be compared to the calculated formula above, using the other values obtained from daily labs (for pre-filter hematocrit) and CRRT machine settings.
Detailed description
This investigational study is listed as other because it is a validation study comparing two measurement methods-comparing a calculated versus a machine-measured post-filter hematocrit- and is typically classified as a cross-sectional investigational study in the context of diagnostic or method comparison research.
Interventions
OTHERCalculated Post-Filter Hematocrit
using the formula: HCTpost=HCTpre/(FF(HCTpre-1)+1)
OTHERMeasured Post-Filter Hematocrit
Measured from blood sample taken from CRRT machine
Sponsors
Gwyndolyn M. Radford
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Intervention model description
All participants will undergo the same intervention of both using their blood samples to measure post-filter hematocrit and using their other lab values and CRRT settings to calculate post-filter hematocrit.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* patients initiated on CRRT age equal than or greater to 18 years of age
Exclusion criteria
* patients on ECMO
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Agreement between measured and calculated post-filter hematocrit values. | Participation begins at consent and includes a single study procedure in which four post-filter blood samples are collected over ~40 minutes. Participation ends after the final draw. Generally, no longer than 1 day. | Use Bland-Altman analysis to assess agreement and quantify bias and limits of agreement. Calculate correlation coefficients (Pearson or Spearman) to evaluate the strength of association. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Analyze the impact of CRRT settings on discrepancies between measured and calculated Filtration Fraction | Participation begins at consent and includes a single study procedure in which four post-filter blood samples are collected over ~40 minutes. Participation ends after the final draw. Generally, no longer than one day. | How do different settings (e.g., Q\_B, Q\_UF, Q\_prefilter, Q\_postfilter) on the machine affect the discrepancies (if there are any) between calculated and measured filtration fraction. Will be using change in post-filter hematocrit values as the measured filtration fraction and comparing to calculated filtration fraction using standard flow-rate derived formula used in practice. |
| Subgroup analysis based on patient-specific factors | Participation begins at consent and includes a single study procedure in which four post-filter blood samples are collected over ~40 minutes. Participation ends after the final draw. | Post-filter hematocrit values will be stratified and compared across subgroups defined by baseline pre-filter hematocrit category, anticoagulation strategy (e.g., citrate vs. heparin vs. none), and blood-flow rate category. The metric reported will be the mean post-filter hematocrit within each subgroup and the between-group differences. |
Countries
United States
Contacts
Primary ContactGwyndolyn M Radford, MD
Backup ContactBenjamin R Griffin, MD
Outcome results
None listed